| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.61 | 2e-62 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-10 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.37 | 4e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |